Table III.
Percent of Participants with Complete (100%) Adherence by Drug Class and Levels of Cognitive Functioning
| Mental development index/Full scale IQ level |
|||||
|---|---|---|---|---|---|
| Drug class | <70 | 70–<85 | 85–100 | >100 | Overall |
| Entire regimen | 205 (88) | 413 (82) | 391 (86) | 207 (87) | 1,216 (85) |
| (n = 232) | (n = 502) | (n = 457) | (n = 238) | (n = 1429) | |
| NRTIs | 207(89) | 419 (84) | 396 (87) | 207 (88) | 1,229 (87) |
| (n = 232) | (n = 498) | (n = 454) | (n = 236) | (n = 1,420) | |
| NNRTIs | 70 (95) | 163 (88) | 145(89) | 68 (94) | 446 (90) |
| (n = 74) | (n = 185) | (n = 163) | (n = 72) | (n = 494) | |
| PIsa | 166 (91) | 305 (83) | 297 (89) | 150 (88) | 918 (87) |
| (n = 183) | (n = 368) | (n = 333) | (n = 171) | (n = 1,055) | |
aPearson's chi-squared test (χ2 = 9.25, df = 3, p =.03).